Abcam plc: Shareholders Board Members Managers and Company Profile | GB00B6774699

Business description: Abcam plc

Abcam plc is a global life science company. The Company serves customers at the forefront of life science research through the identification, development, and distribution of biological reagents. Its products are used by researchers around the world to study biological pathways critical for scientific research, diagnostics, and drug discovery. It offers a selection of products in its catalogue to support research on proteins in biological pathways. Its principal catalogue product lines include primary and secondary antibodies, conjugated antibodies and conjugation kits, and singleplex immunoassays. It offers a range of peptides and proteins, which include cytokines, growth factors, and enzymes. It offers a range of knockout cell lines and lysates, which are used for its in-house validation needs and are also made available to its customers for their own research. It offers a variety of other products, including cellular activity kits, biochemicals and cell signaling pathway tools.

Number of employees: 1,760

Sales by Activity: Abcam plc

Fiscal Period: December	2019 (GBP)	2020 (GBP)	2021 (GBP)	2022 (GBP)
Sales of Antibodies and Related Products	260M	260M	315M	362M

See all business segments

Geographical breakdown of sales: Abcam plc

Fiscal Period: December	2019 (GBP)	2020 (GBP)	2021 (GBP)	2022 (GBP)
The Americas	-	112M	130M	162M
EMEA	-	69.3M	84.3M	90.1M
China	39.9M	39.5M	58.2M	62.9M
Rest of Asia	-	20M	23.8M	28.3M
Japan	16.9M	18.8M	18.7M	17.9M
United Kingdom (UK)	13.6M	-	-	-
Other Countries	58.7M	-	-	-
Germany	15.2M	-	-	-
United States (US)	116M	-	-	-

See all geographic segments

Executive Committee: Abcam plc

Manager	Title	Age	Since
Alan Hirzel CEO	Chief Executive Officer	58	09/09/2014
Markus Lusser PSD	President	58	18/03/2024
Michael Baldock DFI	Director of Finance/CFO	62	03/02/2020
Tommy J. Thomas IRC	Investor Relations Contact	-	27/06/2022
Sun Yi SAM	Sales & Marketing	-	01/10/2018

See ABCAM PLC governance

Composition of the Board of Directors: Abcam plc

Director	Title	Age	Since
Alan Hirzel BRD	Director/Board Member	58	01/01/2014
Mara Aspinall BRD	Director/Board Member	63	14/09/2015
Giles Kerr BRD	Director/Board Member	67	12/12/2018
Michael Baldock BRD	Director/Board Member	62	03/02/2020
Luba Greenwood BRD	Director/Board Member	47	12/09/2022
Markus Lusser BRD	Director/Board Member	58	29/07/2025

Composition of the Board of Directors

Company details: Abcam plc

Abcam Plc

Discovery Drive

CB2 0AX, Cambridge

+44 12 2369 6000

http://www.abcam.com

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MODERNA, INC.	-0.80%	+28.07%	+705.55%	+98.39%	79.4B
REGENERON PHARMACEUTICALS, INC.	-4.54%	-4.15%	+33.40%	-9.65%	78.69B
CSL LIMITED	+2.80%	+3.60%	-6.34%	-27.82%	59.52B
UCB	-0.89%	+2.11%	+7.92%	+170.43%	46.58B
SAMSUNG BIOLOGICS CO.,LTD.	+2.49%	+0.14%	-8.95%	+33.71%	46.53B
BIOGEN INC.	+0.48%	+6.12%	+66.48%	-11.20%	33.63B
INCYTE CORPORATION	+0.75%	-0.39%	+50.93%	+111.17%	25.11B
INNOVENT BIOLOGICS, INC.	-3.56%	-0.47%	+3.11%	+135.37%	22.13B
SWEDISH ORPHAN BIOVITRUM AB	+0.73%	-1.70%	+61.19%	+100.64%	15.31B
Average	-0.14%	+4.30%	+101.48%	+66.78%	45.21B
Weighted average by Cap.	-0.28%	+6.71%	+154.20%	+53.71%